English中文

Offstream
news



Changes

  1. The Israeli Maccabi Healthcare Services said in trial of 602,000 people using Pfizer-BioNTech vaccine, the effectiveness of the vaccine is 95%, meaning that only 608 people tested positive after receiving the second dose.
  2. The Israeli Maccabi Healthcare Services confirmed that in a trial of 602,000 people who received the Pfizer-BioNTech vaccine, the effectiveness of the vaccine was 95%.
  3. The Israeli Maccabi Healthcare Services confirm that in a trial of 602,000 people who received the Pfizer-BioNTech vaccine, the effectiveness of the vaccine was 95%.
  4. The Israeli Maccabi Healthcare Services confirm that, in a trial of 602,000 people who received the Pfizer-BioNTech vaccine, the vaccine's effectiveness was 95%.

Related